Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
491 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Clinical Pathology Asmaa Ahmed Mohamed ahmed 2019
492 Immunohistochemical study of folate receptor-α and mammalian
target of rapamycin in endometrial hyperplasia and
endometrioid endometrial carcinoma


 		Department of Radiotherapy and Nuclear medicine Dr. Asmaa elsayed abdelsalam /hasaballah 2019
493 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
494 The Prognostic Implication of CD49d Expression by
Flow Cytometry and Trisomy 12 Detection by
Fluorescent in situ Hybridization in Chronic
Lymphocytic Leukemia
 		Department of Clinical Pathology Dr. Noha gaber sayed 2019
495 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Radiology Dr. Haisam Ahmed Samy Aly Atta 2019
496 Pediatric Osteosarcoma of Extremities: a 15-year Experience from a Tertiary Care Cancer Center in Upper Egypt Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2019
497 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Department of Clinical Pathology Dr. Abeer Mostafa Mostafa Darwish 2019
498 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Nehal Adel Rayan Mohammed 2019
499 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2019
500 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019